Lorena Diéguez is the leader of the Medical Devices research group at INL. Her research is dedicated to Translational Medical Research in close collaboration with hospitals and focuses on the development of solutions based on microfluidics, biosensors and nanotechnology towards early diagnosis and better understanding of diseases. She is also very interested in translating technologies from the lab to the clinic and is co-founder and CEO of the spin-off company RUBYnanomed in the field of liquid biopsy. Also, since 2019, she is the Chair of the Working Group in Medical Devices at the ETPN (European Technology Platform in Nanomedicine).
She obtained her Bachelors in Physics with Major in Optoelectronics at the University of Santiago de Compostela in 2005, then completed her Masters in Nanotechnology at the University of Barcelona (UB) in 2007 and her PhD in biosensors at the UB, the Institute for Bioengineering of Catalonia and the ETH Zürich. Her postdoc at the University of South Australia (2010-2013) was devoted to the study of rare cells from biological samples using microfluidics.
*Since October 2023, Lorena has temporarily reduced her time at INL to dedicate herself to the development of RUBYnanomed. During this 1-year period, she will be Staff Researcher in the MD group.
Multiplex SERS Phenotyping of Single Cancer Cells in Microdroplets
ADVANCED OPTICAL MATERIALS, 2023
Profiling DNA mutation patterns by SERS fingerprinting for supervised cancer classification
BIOSENSORS & BIOELECTRONICS, 2020